Search Medical Condition
Please enter condition
Please choose location
 

Cherry Hill, New Jersey Clinical Trials

A listing of Cherry Hill, New Jersey clinical trials actively recruiting patient volunteers.

RESULTS

Found (1069) clinical trials

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Patients With Bipolar I Disorder

This study is designed to prospectively confirm the efficacy of a fixed-dose regimen of cariprazine 1.5 mg/day or 3 mg/day compared to placebo for treatment of the depressive episode in patients with bipolar I disorder. The safety and tolerability of the fixed-dose regimens will be evaluated.

Phase

0.45 miles

Learn More »

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

This study will evaluate the efficacy, safety, and tolerability of two doses of rapastinel, 225 milligrams (mg) and 450 mg, compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Phase

0.45 miles

Learn More »

A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

This study will evaluate the efficacy, safety and tolerability of rapastinel 450 milligrams (mg) intravenous (IV) once weekly or once every 2 weeks versus placebo as an adjunctive treatment to ongoing anti-depressive therapy (ADT) in the prevention of relapse in participants with Major Depressive Disorder (MDD).

Phase

0.45 miles

Learn More »

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

This study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).

Phase

0.45 miles

Learn More »

A Study to Evaluate a Drug (Dasotraline) on the Safety Effectiveness and How Well the Body Tolerates it in Adults With Moderate to Severe Binge Eating Disorder

This is a randomized, double-blind, parallel-group, multicenter, outpatient study evaluating the efficacy and safety of 2 doses of dasotraline (4 and 6 mg/day) versus placebo over a 12-week treatment period in adults with BED. This study is projected to randomize approximately 480 subjects to 3 treatment groups in a 1:1:1 ...

Phase

0.45 miles

Learn More »

Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder

This will be an open-label, uncontrolled study which will enroll completers from Study 31-08-250 and new subjects not participating in Studies 250. The treatment history of subjects prior to enrolment in the open-label study will vary according to the design of the pivotal double-blind study (i.e 31-08-250). This open-label study ...

Phase

0.45 miles

Learn More »

A clinical research study evaluating an investigational medication for Its safety and effectiveness in the treatment of Schizophrenia. Eligibility Criteria: 18 years or older Diagnosed with schizophrenia Currently stable Other Details: Eligible participants will receive investigational medication as well as study related tests and procedures at no cost.

0.45 miles

Learn More »

A clinical research study evaluating an investigational drug for its safety and effectiveness in the treatment of Major Depressive Disorder Eligibility Criteria: Be 18 to 65 years old Diagnosed with Major Depressive Disorder Not getting adequate results with current antidepressant therapy Other Details: Eligible participants will receive investigational drug as ...

Phase N/A

0.45 miles

Learn More »

Binge Eating Disorder (B.E.D.) is the most common eating disorder in the United States. If you’re one of the many people who has B.E.D., you may qualify for this medical research study. Individuals with B.E.D. may eat when they are not hungry, eat to the point of being uncomfortably full, ...

Phase N/A

0.45 miles

Learn More »

A clinical research study evaluating an investigational drug for Its safety and effectiveness in the treatment of Major Depressive Disorder.

Phase N/A

0.45 miles

Learn More »